Pathogens and the Bladder: Decoding the Infective Footprints in Bladder Carcinoma

Scritto il 22/11/2026
da Ankana Ganguly

Cureus. 2026 Oct 22;18(10):e118375. doi: 10.7759/cureus.118375. eCollection 2026 Oct.

ABSTRACT

Background and objective While tobacco and chemical carcinogens are established risk factors for urinary bladder carcinoma (UBCA), chronic urinary infection and repeated catheterization may also contribute to urothelial dysplasia and malignant transformation through persistent inflammation and oxidative stress. This study aimed to evaluate infective and clinical correlates of UBCA and determine associations between urinary pathogens, multidrug resistance (MDR), and tumor invasiveness. Methods A 12-month retrospective observational study (January-December 2024) was conducted at Himalayan Institute of Medical Sciences (HIMS), Dehradun, India. Patients with histologically confirmed UBCA (n = 114) undergoing transurethral resection of bladder tumor were included. Age- and sex-matched non-cancer urinary tract infection (UTI) patients served as controls. Preoperative urine cultures were processed according to CLSI (Clinical and Laboratory Standards Institute) guidelines, and antimicrobial susceptibility testing was performed. MDR was defined as resistance to ≥ 3 antimicrobial classes. Clinical variables including recurrent catheterization (≥ 3/year), comorbidities, and lifestyle factors were correlated with tumor grade and invasiveness. Results Among the 114 participants, the mean age was 66 ± 15 years, with a male predominance (77, 68%). Smoking, alcohol use, and viral seropositivity correlated with high-grade malignancy. Among the 114 patients with bladder carcinoma, 78 patients with preoperative urine culture (51, 65.4%) had high-grade disease. Among these 78 patients, Gram-negative uropathogens were isolated in 40 cases (51.3%). Among the 114 patients with bladder carcinoma, 40 (35.1%) had a history of recurrent catheterization. Of these, bacterial growth was observed in 38 (95%) patients, and two (5%) had sterile culture. Predominant isolates were Klebsiella pneumoniae (K. pneumoniae) (12, 30.0%), Escherichia coli (E. coli) (nine, 22.5%), and Proteus mirabilis (P. mirabilis) (six, 15.0%), followed by Pseudomonas aeruginosa (P. aeruginosa) (four, 10.0%) and Klebsiella oxytoca (K. oxytoca) (three, 7.5%). Enterococcus faecalis (E. faecalis) was isolated in four (10.0%) patients, while two (5.0%) had sterile cultures. Recurrent catheterization strongly correlated with muscle-invasive disease, with 27 (81.8%) out of 33 muscle-invasive patients (p < 0.001). Gram-negative infection increased odds of invasiveness (OR = 3.1, p = 0.002). Culture-positive patients had significantly larger tumors (5.4 vs. 2.8 cm; p < 0.0001). MDR organisms were identified in 30 of 78 bladder carcinoma patients with available preoperative urine culture results (38.5%), compared with 12 of 80 non-cancer UTI controls (15%). Conclusions Chronic infection, recurrent catheterization, and MDR Gram-negative pathogens showed an association with muscle-invasive bladder carcinoma. Routine microbiological surveillance, targeted antimicrobial therapy, and infection-control strategies should be integrated into uro-oncologic management.

PMID:43068329 | PMC:PMC13788874 | DOI:10.7759/cureus.118375